University of Massachusetts, Worcester
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Massachusetts, Worcester sits in the top decile of US sponsors by registered trial count (#136 of 15,742 sponsors by registered trial count).
University of Massachusetts, Worcester: 240 sponsored US clinical trials, 30 recruiting.
University of Massachusetts, Worcester sponsors 240 registered US clinical trials on ClinicalTrials.gov, 30 of them currently recruiting, and 177 completed. 23 of these trials are in Phase 3-4 (later-stage) and 38 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alcohol Use Disorder, with 4 trials.
Top-decile sponsor footprint
University of Massachusetts, Worcester ranks in the top decile of sponsors by registered trial count (#136 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
177 of 191 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
240 total, page 5 of 5
Perioperative Intervention to Improve Post-TKR Support and Function
NCT00566826
Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins
NCT00750867
PACT (Platelet Activity After Clopidogrel Termination)
NCT00619073
IRS Proteins and Trastuzumab Resistance
NCT00657345
Intranasal Insulin Treatment in Patients With Schizophrenia
NCT00575666
Comparison Study of Wound Closure at Time of Cesarean Delivery: Dermabond Glue Versus Surgical Staples
NCT00524511
Safety Study of Dantrolene to Treat Cerebral Vasospasm After Subarachnoid Hemorrhage
NCT00964548
Effectiveness of Behavioral Treatments for Obesity and Major Depression in Women
NCT00572520
Evaluate The Toxicity And Feasibility Of Intra-Tumoral Injection
NCT00668382
Cancer Dietary Objectives Study
NCT00561977
Intratumoral Injection Of Alpha-Gal Glycosphingolipids
NCT00668512
Exhaled Breath Condensate pH in Patients With Cough Caused by Gastroesophageal Reflux
NCT00451841
Assessment of Insulin Resistance, NAFLD, Predictors of CV Morbidity, and Subcutaneous Adipose and Visceral Adipose Gene Expression in Patients Undergoing Gastric Bypass Surgery
NCT01007955
Effect of Rosiglitazone on the Vascular Biology of Human Fat Tissue
NCT01150981
Effect of Single Dose Intranasal Insulin On Cognitive Function
NCT00646581
School Nurse-Delivered Smoking Cessation Intervention
NCT00682474
Enhancing the Safety of Warfarin in Nursing Homes
NCT00682773
Asthma and Mindfulness-Based Stress Reduction (MBSR)
NCT00682669
Memantine Augmentation of Antidepressants
NCT00344682
Phase I/II Study to Evaluate the Efficacy and Safety of a Combination Chemotherapy
NCT00424840
Investigation of a Behavioral Substitute for Sunbathing
NCT00403377
Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin (AAT) Deficiency
NCT00430768
Mindfulness-Based Stress Reduction for Hot Flashes
NCT01052454
The IGFBP-3 Stimulation Test: A New Tool for the Diagnosis of Growth Hormone Deficiency in Children.
NCT00235599
Diabetic Educational Eating Plan
NCT00473811
Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves Disease
NCT00946296
Outcomes of Bariatric Surgery/UMMMC Bariatric Surgery Registry
NCT01153308
Mindfulness Based Stress Reduction for Hot Flashes
NCT00317304
Health Information Technology in the Nursing Home
NCT00599209
Montelukast for Early Life Wheezing
NCT00115297
Workplace-Sponsored Diet and Exercise Program to Reduce Obesity
NCT00123526
Diabetes Management in Low-Income Hispanic Patients
NCT00848315
Lawrence Latino Diabetes Prevention Project
NCT00810290
STEP: Social Support To Empower Parents
NCT00480493
In-exsufflator Cough Assist Device in Patients With Symptomatic Bronchiectasis
NCT00452114
Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin Deficiency
NCT00377416
Long Term Use of Valganciclovir for Prophylaxis of CMV Disease in Kidney and Pancreas Transplant Patients
NCT00225394
Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
NCT00530244
Improving Adherence to Pharmacological Treatment
NCT00848224
Provider and Peer Delivered Youth Smoking Intervention
NCT00435344
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 24 |
| Phase 2 | 14 |
| Phase 3 | 11 |
| Phase 4 | 12 |
Therapeutic Areas
What is open in the University of Massachusetts, Worcester pipeline
30 recruiting of 240 indexed (13% open); 177 completed (74%).
Phase mix: 23 late (III/IV) vs 38 early (I/II) (early-phase heavy).
Top condition: Alcohol Use Disorder (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Massachusetts, Worcester: open-pipeline peers nationwide
Peers matched on 240 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Massachusetts, Worcester sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 240 trials (± recruiting share)
- Incyte Corporation · 239 trials · 15% recruiting
- State University of New York at Buffalo · 243 trials · 21% recruiting
- Loma Linda University · 237 trials · 15% recruiting
- Daiichi Sankyo · 236 trials · 12% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Addario Lung Cancer Medical Institute · 13% recruiting · 8 trials
- American University · 13% recruiting · 16 trials
- Annexon · 13% recruiting · 8 trials
- Ansun Biopharma · 13% recruiting · 8 trials
Related
What to do with this University of Massachusetts, Worcester page
240 registered trials is a research-attention snapshot, not an endorsement of University of Massachusetts, Worcester or any single study.
- 30 of University of Massachusetts, Worcester's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alcohol Use Disorder is the condition University of Massachusetts, Worcester studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alcohol Use Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Massachusetts, Worcester pipeline card: 240 registered trials from official public datasets.Report a data error.